A few simple facts to get you started with the Copay Assistance Program

Who is eligible to save?*

If you've been prescribed REGRANEX (becaplermin) gel, 0.01% and pay more than $25 out of pocket for your prescription, whether you're insured or not, you may be eligible to save. Participants in governmental healthcare programs or where copay assistance is taxed, restricted, or otherwise prohibited by law are not eligible.

Just how much will I save?

Eligible recipients will pay the first $25; Smith+Nephew will pay the remaining out-of-pocket cost up to the next $200.*

How does it work?*

Click the print card button to start printing your Copay Assistance Program card. Then, just give the printed card to your pharmacist, along with your insurance card (if you have one) and a valid prescription for REGRANEX gel. The amount you receive from the program will be subtracted from what you pay your pharmacy.

*Subject to the Copay Assistance Program Card Terms and Conditions below and on the back of the card.

Please be sure to read the "What is REGRANEX gel?" and "Important Safety Information" sections below, as well as the patient Medication Guide at the end of the REGRANEX gel Prescribing Information.

For more information about REGRANEX gel, please review the patient Medication Guide and talk with your healthcare provider.

Copay Assistance Program Terms and Conditions

Not valid for prescriptions eligible to be reimbursed under Medicare (including Medicare part D and Medicare Advantage), Medicaid, TRICARE, CHAMPUS, the Puerto Rico Governmental Health Insurance Plan, or other federal, state, or governmental healthcare programs. Valid in the U.S. only, void where taxed, restricted, or prohibited by law. Accepted by participating pharmacies only. This Copay Assistance Program is not insurance and may be changed or discontinued at any time without notice.

What is REGRANEX gel?

REGRANEX is a protein medicine made in yeast that is used with other ulcer care practices (such as good wound care) to treat diabetic sores (ulcers) of your legs or feet that are deeper than just your skin, in people who have good blood supply to the legs.

It is not known if REGRANEX is effective for the treatment of pressure ulcers or ulcers that are due to poor blood flow (circulation). It is not known if REGRANEX is safe and effective in children under 16 years of age.


REGRANEX (becaplermin) gel 0.01% is indicated for treating lower extremity diabetic ulcers that extend under the skin and have adequate blood supply. The effectiveness of REGRANEX has not be established in pressure ulcers, or venous ulcers. REGRANEX is not a substitute for good ulcer care practices. REGRANEX is contraindicated for patients with a tumor at the site(s) of application. REGRANEX is non-sterile so it should not be used in wounds that heal without tissue loss (primary intention). Side effects include rashes, burning sensation, and redness at the site of application. Tumors distant from the site of application have been reported in both a clinical study and in real world use. The risk information provided herein is not comprehensive. To see the complete prescribing information, please see the FDA-approved product labeling, here: You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.


©2020 Smith+Nephew, Inc. All rights reserved.
♢Trademark of Smith+Nephew, Inc.

This website is intended for individuals age 18 and over in the United States only. The information provided is for information purposes only and is not intended to be medical advice. It does not replace the professional training, experience , and knowledge of the healthcare provider responsible for patient care, who must base treatment upon the unique characteristics of each patient.

If you have questions about REGRANEX (becaplermin) gel, 0.01%, that are not answered by this website; contact your healthcare provider.